US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 9, 2018 (9 years ago)

Cyclosporine USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

What was recalled

Cyclosporine USP, for prescription compounding, packaged in a) 5g (NDC 58597-8210-2); b) 10g (NDC 58597-8210-3); c) 100g, NDC 58597-8210-6; d) 500g (NDC 58597-8210-7), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

Recalling firm
American Pharmaceutical Ingredients LLC
NDC code
58597-8210-2
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0482-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Cyclosporine recalls

See all
Class III · Low risk Ongoing

Klarity-C Drops

Reason Subpotent Drug

Imprimis NJOF, LLC NDC 71384-514-05 D-0157-2026
Class II · Moderate risk Ongoing

Klarity-C

Reason Lack of Assurance of Sterility

Imprimis NJOF, LLC D-0547-2024
Class I · High risk Ongoing

SANDIMMUNE Oral Solution

Reason Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals

Novartis Pharmaceuticals Corporation NDC 0078-0110-22 D-0144-2024
Class I · High risk Ongoing

SANDIMMUNE Oral Solution

Reason Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals.

Novartis Pharmaceuticals Corp. NDC 0078-0110-22 D-1174-2023
Class III · Low risk Terminated

Cequa

Reason Subpotent: Out of Specification result observed for low assay

Sun Pharmaceutical Industries INC NDC 47335-506-96 D-1172-2023